Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients

NCT04226105 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

264

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Diabetes Mellitus

Interventions

DRUG: GP40081
DRUG: NovoMix 30

Sponsor

Geropharm